Inactive Instrument

Syncom Healthcare Limited Stock

Equities

SYNCOM

INE602K01014

Pharmaceuticals

Dynamic Chart
Syncom Healthcare Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2021 CI
Syncom Healthcare Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021 CI
Syncom Healthcare Limited Announces Resignation of Farida Bhatia as Company Secretary Cum Compliance Officer CI
Syncom Healthcare Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2020 CI
Syncom Healthcare Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2020 CI
Syncom Healthcare Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2020 CI
Syncom Healthcare Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020 CI
Syncom Healthcare Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2019 CI
Syncom Healthcare Limited Announces Address Change CI
Syncom Healthcare Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2019 CI
Syncom Healthcare Limited Announces Board Changes CI
Syncom Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2019 CI
Syncom Healthcare Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2019 CI
Syncom Healthcare Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2019 CI
Syncom Healthcare Limited Appoints Bhishampal Singh Yadav as Additional Director CI
More news
Managers TitleAgeSince
Chief Executive Officer 63 02-07-28
Director of Finance/CFO - 17-12-17
Members of the board TitleAgeSince
Chief Executive Officer 63 02-07-28
Director/Board Member 51 14-11-11
Director/Board Member 57 14-11-11
More insiders
Syncom Healthcare Limited is engaged in manufacturing of pharmaceuticals. The Company is an integrated international pharmaceutical company with businesses encompassing the value chain in the marketing, production (including job work) and distribution of pharmaceutical products. The Company operates through pharmaceuticals formulations segment. The Company in the domestic market, has approximately two main focus areas of operations: contract/toll manufacturing and over the counter (OTC). Through its OTC operations, the Company functions in three segments namely, generic, ethical, and the pharma OTC. The Company undertakes contract manufacturing for various pharmaceutical formulations, neutraceutical products, food supplements and cosmetics, which include tablets, capsules, syrups/liquid orals, eye-ear drops, creams and ointments, oral dry powders (Non-beta lactam), protein powders, external preparations (Oils and Liniments) and herbal preparations.
More about the company
  1. Stock Market
  2. Equities
  3. SYNCOM Stock